UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~April~~May 2025

Commission file number: 001-34958

EASON TECHNOLOGY LIMITED

23rd Floor, Lianfa International Building

128 Xudong Road, Wuchang District

Wuhan City, Hubei Province 430063

People’s Republic of China

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

Form 20-F ☒ Form 40-F ☐

~~Appointment~~Notice of ~~Director~~Delisting ~~and~~or ~~Officer~~Failure to Satisfy a Continued Listing Rule

~~Effective~~On onMay ~~March 14~~16, 2025, ~~Mr.~~Eason ~~Weidong~~Technology XuLimited ~~resigned~~(“Eason Technology” or the “Company”) received a notice from ~~his~~NYSE ~~positions~~Regulation indicating that the Company is not in compliance with ~~Eason~~the ~~Technology~~continued ~~Limited~~listing standards of NYSE American LLC (“NYSE American” or the “~~Company~~Exchange”). The Company failed to timely file its Form 20-F for the period ended December 31, ~~including~~2024 as(the a“2024 ~~member~~Form of20-F”) by the ~~board~~filing due date of ~~directors~~May 15, 2025 (the “~~Board~~Filing Delinquency”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company. Guide

OnNYSE ~~March~~Regulation ~~26,~~notified ~~2025,~~the Company that NYSE American will closely monitor the ~~Board~~status ~~ratified~~of the Company’s 2024 Form 20-F and ~~appointed~~any ~~Mr.~~subsequent ~~Jun~~delayed Hufilings for a six-month period from the date of the Filing Delinquency until November 15, ~~Mr.~~2025 ~~Stephen~~(the ~~Liao~~“Initial ~~and~~Cure MrPeriod”). ~~Halen~~If Futhe asCompany ~~independent~~fails ~~directors~~to ofcure the ~~Board~~Filing ofDelinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company’s ~~and~~securities to be traded for up to an additional six-month period until May 15, 2026 (the ~~Board~~“Additional Cure Period”) depending on the Company’s ~~committees~~specific ~~listed below~~circumstances. ~~The~~If ~~Company~~the ~~extended~~Exchange ~~director~~determines ~~offer~~that ~~letters~~an toAdditional ~~each~~Cure ofPeriod ~~the~~is ~~independent~~not ~~directors~~appropriate, ~~which~~suspension ~~establish~~and ~~certain~~delisting ~~terms~~procedures ~~and~~will ~~conditions~~commence ~~governing~~in accordance with the ~~independent~~procedures ~~directors’~~set ~~services~~out in Section 1010 hereof. If the Exchange determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file the 2024 Form 20-F and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.

~~Mr.~~As ~~Jun~~disclosed Huin isthe ~~working~~Form as12b-25 ~~the~~filed ~~president~~by inthe TKCompany ~~Health~~on ~~Technology~~April ~~Co.~~30, ~~Ltd.~~2025, athe ~~pharmaceutical~~Company ~~chain~~was ~~company~~unable, ~~responsible~~without ~~for~~unreasonable ~~strategy~~effort ~~and~~or ~~operational~~expense, ~~management~~to ~~from~~file ~~February~~its 2024 ~~until~~Form ~~present.~~20-F ~~From~~as ~~October~~a ~~2019~~result toof ~~January~~a ~~2024~~delay in completing its financial statements for the period ended December 31, Mr2024. ~~Jun~~The HeCompany ~~worked~~was asnot aable ~~director~~to inmake ~~Stone~~the ~~Energy~~required ~~Technology~~filing ~~Co.~~by May 15, ~~Ltd~~2025., ~~responsible~~The ~~for~~Company ~~business~~is ~~development~~making ~~and~~all ~~mergers~~efforts to file the 2024 Form 20-F as soon as possible and ~~acquisitions~~within ~~business.~~the MrInitial Cure Period. HuHowever, ~~received~~there ~~his~~can ~~bachelor’s~~be ~~degree~~no ofassurance ~~economics~~that inthe ~~accounting~~Company ~~from~~will ~~Hubei~~ultimately ~~University~~regain incompliance ~~2013~~with all applicable Exchange listing standards.

~~Mr.~~This ~~Stephan~~delinquency ~~Liao~~notice ishas ~~working~~no asimmediate ~~the~~impact ~~vice~~on ~~president of~~ the ~~South~~listing ~~China~~of ~~Region in iSoftStone Information Technology (Group) Co., Ltd., a company in~~ the ~~software~~Company’s ~~and information technology services industry~~ADSs, ~~responsible~~which ~~for~~will ~~software~~continue ~~development~~to ~~and~~be ~~digital~~listed ~~technology service team management, key customer service~~ and ~~market~~traded ~~expansion,~~on ~~from~~the ~~April~~NYSE ~~2014~~American ~~until~~during ~~present.~~the ~~Mr.~~cure ~~Liao~~period ~~obtained~~subject ~~his~~to ~~bachelor’s~~continued ~~degree~~compliance inwith ~~computer~~the ~~science~~other ~~and~~listing ~~technology~~requirements ~~from~~of ~~Jiangxi~~the ~~Normal~~NYSE ~~University in 2008~~American.

~~Mr.~~On ~~Halen~~May ~~Fu is working as the vice president of Zhengda Medical Group Co.~~23, ~~Ltd. from February 2022 until present~~2025, ~~responsible~~the ~~for~~Company ~~risk~~issued ~~and~~a ~~compliance~~press ~~management.~~release ~~Mr.~~announcing Fureceipt ~~worked~~of as the ~~compliance~~delinquency ~~director in Dezhao Capital Management Co~~notice., ~~Ltd.~~A ~~from~~copy ~~October~~of ~~2017~~the topress ~~January~~release ~~2022,~~is ~~responsible~~attached ~~for~~hereto ~~project~~as ~~and~~Exhibit ~~investment review~~99.1 ~~Mr. Fu obtained his bachelor’s degree of economics in finance from Hunan University of Finance~~ and ~~Economics~~is inincorporated ~~1996,~~herein ~~and~~by ~~his master’s degree of business administration from Wuhan University in 2005~~reference.

Each of Mr. Hu, Mr. Liao and Mr. Fu does not have a family relationship with any director or executive officer of the Company and has not been involved in any transaction with the Company during the past two years that would require disclosure under Item 404(a) of Regulation S-K.

The foregoing description of the director offer letters is a general description only, does not purport to be complete, and is qualified in its entirety by reference to the terms of the form of director offer letters attached hereto as Exhibit 99.1, which is incorporated herein by this reference.

The following table sets forth the Board’s committee composition as of the date of this report:

Committee Chairperson Member Member Member Audit Committee Hao Xu Siyuan Xu Halen Fu Stephen Liao Nominating Committee Halen Fu Siyuan Xu Stephan Liao - Compensation Committee Stephen Liao Halen Fu Siyuan Xu -

Exhibit Index

Exhibit No.		Description
99.1		Form of Director Offer Letter

Exhibit Index

Exhibit No.		Description
99.1		Press Release

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Eason Technology Limited
Date: April 1, 2025	By:	/s/ Longwen (Stanley) He
Date: May 23, 2025	By:	/s/ Longwen (Stanley) He
	Name:	Longwen (Stanley) He
	Title:	Chief Executive Officer

Filing Compare · Eason Technology Ltd